According to Xilio Therapeutics's latest financial reports the company's current earnings (TTM) are -โน5.77 B. In 2022 the company made an earning of -โน7.48 B a decrease over its 2021 earnings that were of -โน6.3 B.The earnings displayed on this page is the company's Pretax Income.